BELOMETHASONE 200 PRESSURISED 200MCG INHALER

Indications

• Asthma
• Allergic rhinitis
• Psoriasis
• Eczema
• Rheumatoid arthritis
• Systemic lupus erythematosus

Dosage

Children: Refer to established guidelines or prescribing information for specific dosing recommendations.

Adults: Refer to established guidelines or prescribing information for specific dosing recommendations.

Mechanism of action

Belomethasone acts by binding to glucocorticoid receptors, leading to the regulation of gene expression. This results in the inhibition of pro-inflammatory cytokines and enzymes, reducing inflammation and modulating immune responses. Additionally, it suppresses the migration of leukocytes to sites of inflammation and decreases the permeability of capillaries, thus alleviating symptoms associated with inflammatory processes.

Pharmacodynamics

Belomethasone exhibits potent anti-inflammatory effects by inhibiting the synthesis of inflammatory mediators, including prostaglandins and leukotrienes. Its immunosuppressive effects stem from its ability to inhibit the proliferation and function of immune cells, particularly T lymphocytes. The onset of action can vary based on the route of administration, but therapeutic effects are generally observed within hours to days.

Pharmacokinetics

Belomethasone is typically well absorbed when administered, with a bioavailability that can be affected by the route of administration. It is extensively metabolized in the liver, and its metabolites are excreted primarily via the kidneys. The drug has a relatively long half-life, allowing for once-daily dosing in many cases. Its pharmacokinetics can be influenced by factors such as age, liver function, and the presence of other medications.

Contra-indications

• Hypersensitivity to belomethasone or any of its components
• Active infections unless treated
• Systemic fungal infections

Adverse effects

• Skin irritation
• Burning sensation
• Atrophy of the skin
• Hyperpigmentation
• Allergic contact dermatitis
• Striae formation

Interactions

• Corticosteroids may interact with other medications that affect the immune system
• Concurrent use of other topical corticosteroids may enhance the risk of systemic absorption and side effects

Precautions

• Use with caution in patients with a history of skin infections
• Avoid prolonged use on large areas of the body
• Monitor for signs of local or systemic side effects, especially in pediatric patients

Pregnancy

Belomethasone should be used during pregnancy only if the potential benefit justifies the potential risk to the fetus. Adequate studies are not available.

Breast-feeding

Caution is advised when administering belomethasone to breastfeeding mothers. The effects on the nursing infant are unknown.

Storage

Store at room temperature, away from light and moisture. Do not freeze.

Formulations

• Topical cream
• Topical ointment
• Topical solution

Indications

• Asthma
• Chronic Obstructive Pulmonary Disease (COPD)
• Allergic Rhinitis
• Cystic Fibrosis
• Pulmonary Hypertension

Dosage

Children: Refer to specific inhaled medication guidelines for paediatric dosing.

Adults: Refer to specific inhaled medication guidelines for adult dosing.

Mechanism of action

Inhaled medications can have various mechanisms of action depending on the specific drug. For example, beta-2 adrenergic agonists stimulate beta-2 receptors on bronchial smooth muscle, leading to bronchodilation. Corticosteroids inhibit the expression of inflammatory mediators and reduce airway inflammation, while anticholinergics block acetylcholine from binding to its receptors, resulting in decreased bronchoconstriction.

Pharmacodynamics

The pharmacodynamics of inhaled medications involve their interaction with specific receptors or pathways in the lungs. Bronchodilators cause relaxation of the bronchial smooth muscle, leading to increased airflow. Corticosteroids effectively reduce inflammation and mucus production in the airways, thereby improving respiratory function and reducing exacerbations of asthma and COPD. The rapid delivery of these drugs to the site of action enhances their efficacy.

Pharmacokinetics

Inhaled medications have distinct pharmacokinetic properties. The onset of action can be very rapid, often within minutes, due to direct delivery to the lungs. The bioavailability depends on factors such as particle size, inhalation technique, and the type of inhaler used. Systemic absorption is generally lower than with oral medications, which minimizes systemic side effects. The duration of action varies based on the specific drug class; for example, short-acting beta agonists provide quick relief, while long-acting agents offer prolonged effects.

Pregnancy

Consult healthcare provider for risk assessment and guidance, as safety data may vary depending on the specific inhalation formulation.

Breast-feeding

Consult healthcare provider, as some inhalation medications may be excreted in breast milk and could affect the infant.

Storage

Store in a cool, dry place away from direct sunlight. Check specific product guidelines for temperature and humidity requirements.

Indications

• Asthma
• Chronic obstructive pulmonary disease (COPD)
• Exercise-induced bronchoconstriction
• Allergic rhinitis (in some cases)

Dosage

Children: Refer to specific product guidelines for dosage, as it varies by formulation and active ingredient.

Adults: Refer to specific product guidelines for dosage, as it varies by formulation and active ingredient.

Mechanism of action

The mechanism of action varies depending on the active ingredient in the pressurized formulation. For example, beta-2 adrenergic agonists, such as albuterol, work by stimulating beta-2 adrenergic receptors in bronchial smooth muscle, leading to relaxation and bronchodilation. Corticosteroids, like fluticasone, exert their effects by binding to glucocorticoid receptors, inhibiting the inflammatory response, and reducing airway hyperreactivity.

Pharmacodynamics

The pharmacodynamics of pressurized medications involve their ability to produce a therapeutic effect through local action in the lungs. The onset of action can be rapid, particularly for bronchodilators, which may relieve symptoms of bronchospasm within minutes. The efficacy of corticosteroids develops over time, reducing inflammation and improving lung function. The therapeutic effect is often measured by improvements in airflow, reduced symptoms, and decreased need for rescue medication.

Pharmacokinetics

Pharmacokinetics of pressurized medications can vary widely based on the specific drug. Generally, these agents have a rapid absorption and onset of action due to their delivery route. Systemic absorption may occur, especially with corticosteroids, leading to potential systemic effects. The distribution of the drug can be localized primarily in the lungs, with varying degrees of systemic bioavailability. Metabolism and excretion also depend on the specific active ingredients, with many being metabolized in the liver and excreted via the kidneys.

Pregnancy

Safety during pregnancy has not been established. Use only if the potential benefit justifies the potential risk to the fetus.

Breast-feeding

Caution is advised when using during breastfeeding. It is not known whether the drug is excreted in human milk.

Storage

Store in a cool, dry place away from direct sunlight. Keep out of reach of children.